351 related articles for article (PubMed ID: 15337607)
21. Reconstitution of the fatty acid hydroxylase activity of cytochrome P450BM-3 utilizing its functional domains.
Sevrioukova I; Truan G; Peterson JA
Arch Biochem Biophys; 1997 Apr; 340(2):231-8. PubMed ID: 9143326
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the interactions of cytochrome b5 with flavocytochrome P450 BM3 and its domains.
Noble MA; Girvan HM; Smith SJ; Smith WE; Murataliev M; Guzov VM; Feyereisen R; Munro AW
Drug Metab Rev; 2007; 39(2-3):599-617. PubMed ID: 17786641
[TBL] [Abstract][Full Text] [Related]
23. Affinity isolation and characterization of cytochrome P450 102 (BM-3) from barbiturate-induced Bacillus megaterium.
Black SD; Linger MH; Freck LC; Kazemi S; Galbraith JA
Arch Biochem Biophys; 1994 Apr; 310(1):126-33. PubMed ID: 8161195
[TBL] [Abstract][Full Text] [Related]
24. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
[TBL] [Abstract][Full Text] [Related]
25. Roles of key active-site residues in flavocytochrome P450 BM3.
Noble MA; Miles CS; Chapman SK; Lysek DA; MacKay AC; Reid GA; Hanzlik RP; Munro AW
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):371-9. PubMed ID: 10191269
[TBL] [Abstract][Full Text] [Related]
26. Preparative use of isolated CYP102 monooxygenases -- a critical appraisal.
Eiben S; Kaysser L; Maurer S; Kühnel K; Urlacher VB; Schmid RD
J Biotechnol; 2006 Aug; 124(4):662-9. PubMed ID: 16716428
[TBL] [Abstract][Full Text] [Related]
27. The unusual redox properties of flavocytochrome P450 BM3 flavodoxin domain.
Hanley SC; Ost TW; Daff S
Biochem Biophys Res Commun; 2004 Dec; 325(4):1418-23. PubMed ID: 15555585
[TBL] [Abstract][Full Text] [Related]
28. Improving catalytic properties of P450 BM3 haem domain electrodes by molecular Lego.
Fantuzzi A; Meharenna YT; Briscoe PB; Sassone C; Borgia B; Gilardi G
Chem Commun (Camb); 2006 Mar; (12):1289-91. PubMed ID: 16538250
[TBL] [Abstract][Full Text] [Related]
29. Protein engineering of the cytochrome P450 monooxygenase from Bacillus megaterium.
Urlacher VB; Schmid RD
Methods Enzymol; 2004; 388():208-24. PubMed ID: 15289074
[No Abstract] [Full Text] [Related]
30. [Electrochemical measurement of intraprorein and interprotein electron transfer].
Shumiantseva VV; Bulko TV; Lisitsina VB; Urlakher VB; Kuzikov AB; Suprun EV; Archakov AI
Biofizika; 2013; 58(3):453-60. PubMed ID: 24159813
[TBL] [Abstract][Full Text] [Related]
31. P450BM-3: absolute configuration of the primary metabolites of palmitic acid.
Truan G; Komandla MR; Falck JR; Peterson JA
Arch Biochem Biophys; 1999 Jun; 366(2):192-8. PubMed ID: 10356283
[TBL] [Abstract][Full Text] [Related]
32. Flavin supported fatty acid oxidation by the heme domain of Bacillus megaterium cytochrome P450BM-3.
Gonvindaraj S; Li H; Poulos TL
Biochem Biophys Res Commun; 1994 Sep; 203(3):1745-9. PubMed ID: 7945324
[TBL] [Abstract][Full Text] [Related]
33. Interaction of nitric oxide with cytochrome P450 BM3.
Quaroni LG; Seward HE; McLean KJ; Girvan HM; Ost TW; Noble MA; Kelly SM; Price NC; Cheesman MR; Smith WE; Munro AW
Biochemistry; 2004 Dec; 43(51):16416-31. PubMed ID: 15610036
[TBL] [Abstract][Full Text] [Related]
34. Formation of flavin semiquinone during the reduction of P450 BM3 reductase domain with NADPH.
Munro AW; Coggins JR; Lindsay JG; Daff S; Chapman SK
Biochem Soc Trans; 1996 Feb; 24(1):18S. PubMed ID: 8674656
[No Abstract] [Full Text] [Related]
35. Catalytically self-sufficient P450 CYP102 (cytochrome P450 BM-3): resonance Raman spectral characterization of the heme domain and of the holoenzyme.
Hudeèek J; Baumruk V; Anzenbacher P; Munro AW
Biochem Biophys Res Commun; 1998 Feb; 243(3):811-5. PubMed ID: 9500975
[TBL] [Abstract][Full Text] [Related]
36. Dicamba monooxygenase: structural insights into a dynamic Rieske oxygenase that catalyzes an exocyclic monooxygenation.
D'Ordine RL; Rydel TJ; Storek MJ; Sturman EJ; Moshiri F; Bartlett RK; Brown GR; Eilers RJ; Dart C; Qi Y; Flasinski S; Franklin SJ
J Mol Biol; 2009 Sep; 392(2):481-97. PubMed ID: 19616009
[TBL] [Abstract][Full Text] [Related]
37. Probing electron transfer in flavocytochrome P-450 BM3 and its component domains.
Munro AW; Daff S; Coggins JR; Lindsay JG; Chapman SK
Eur J Biochem; 1996 Jul; 239(2):403-9. PubMed ID: 8706747
[TBL] [Abstract][Full Text] [Related]
38. Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450.
Otey CR; Bandara G; Lalonde J; Takahashi K; Arnold FH
Biotechnol Bioeng; 2006 Feb; 93(3):494-9. PubMed ID: 16224788
[TBL] [Abstract][Full Text] [Related]
39. Deflavination of cytochrome P450 BM3 by treatment with guanidinium chloride.
Munro AW; Coggins JR; Lindsay JG; Kelly S; Price NC
Biochem Soc Trans; 1996 Feb; 24(1):19S. PubMed ID: 8674659
[No Abstract] [Full Text] [Related]
40. The role of the conserved threonine in P450 BM3 oxygen activation: substrate-determined hydroxylation activity of the Thr268Ala mutant.
Cryle MJ; De Voss JJ
Chembiochem; 2008 Jan; 9(2):261-6. PubMed ID: 18161730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
